Duko Drijfhout is responsible for new venturing and investment management at Erasmus University Medical Center, one of the largest medical centers in Europe. Having been active in the entrepreneurial space for the past three decades, Erasmus MC has seen entrepreneurial successes such as Quantib (now part of RadNet Inc.), Harbour Biomed (listed a HKEX) and ViroNovative, as well as partnering multiple blockbuster drugs with industry. Erasmus MC is developing a novel business campus focused on MedTech companies.

In over 15 years in the Life Sciences & Health industry, Duko held different roles at UNIIQ, one of the most active early stage investment funds in Europe and was COO of Theranostics Erasmus MC. He is a board member and business advisor to multiple (MedTech) companies and operates as CEO of NeOncoFRAx. Duko holds a degree in Finance & Investments from the Rotterdam School of Management and is a ScaleUpNational certified board member.